Last mentioned: Mar 24, 2026
Earnings Super Tuesday
Reed's, Intrusion Inc., and TELA Bio all release Q4 and Full Year 2025 results.
TELA Bio Listing Alert
TELA Bio receives notice of failure to satisfy Nasdaq listing rules.
Reed's Preliminary Shift
Reed's Inc. files 8-K regarding departure of directors or certain officers.
Reed’s, Intrusion Inc., and TELA Bio released Q4 and full-year 2025 results, highlighting a period of transition for several micro-cap players. While Reed’s announced a significant leadership change, TELA Bio faces regulatory challenges following a recent delisting notice.
This page surfaces every story mentioning TELA Bio across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where TELA Bio was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |